DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect of Mass Deworming on Child Growth

Information source: Makerere University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Low Weight for Age in Preschool Children

Intervention: Albendazole 400 mg, given 6 monthly (Drug)

Phase: N/A

Status: Completed

Sponsored by: Makerere University

Official(s) and/or principal investigator(s):
Joseph K Konde-Lule, MD DPH MSc, Principal Investigator, Affiliation: Makerere University
John F Mutumba, MBChB, MSc, Study Chair, Affiliation: Ministry of Health, Uganda

Summary

The purpose of the study was to determine whether periodical mass deworming improves growth in children below six years of age.

Clinical Details

Official title: Increased Weight Gain in Preschool Children Due to Mass Albendazole Treatment Given During "Child Health Days" in Uganda

Study design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study

Primary outcome:

weight gain

weight for age

Detailed description: Many children in developing countries get slowed growth because of heavy loads of intestinal helminths. Quite often treatment is not sought because there may not be any obvious symptoms. Slowed growth may manifest as low weight for age or low height for age.

The objective of the study was to estimate the effectiveness of the delivery of an anthelmintic drug through a community child health program on the weight gain of preschool aged children.

Design: This was a cluster randomized controlled trial in 48 parishes in Eastern Uganda. All 48 parishes were participating in a new program for child health; 24 were randomly assigned to offer to children an additional service of anthelmintic treatment. The intervention was 400 mg of albendazole added to the standard services at child days over a 3 years period. All children were offered the drug and the main outcome measure was weight gain.

Results: A total of 27,995 children were recruited into the 2 arms of the study with 14,940 in the treatment arm and 13,055 in the control arm. The intervention arm got an increase in weight gain of about 10% (166 grams per child per year (CI: 16-316) above expected weight gain when treatment was taken twice a year and an increase of 5% when treatment was received approximately annually.

Conclusion: The inclusion of deworming in regularly scheduled health services appears practical and capable of increasing child growth.

Eligibility

Minimum age: 1 Year. Maximum age: 7 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- children 1-6 years

Exclusion Criteria:

-

Locations and Contacts

48 parishes in Eastern Uganda, Kampala, Uganda
Additional Information

Starting date: August 2000
Ending date: November 2003
Last updated: October 16, 2006

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009